Frédéric Le Gal

2.4k total citations
45 papers, 1.6k citations indexed

About

Frédéric Le Gal is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Frédéric Le Gal has authored 45 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 39 papers in Hepatology and 5 papers in Infectious Diseases. Recurrent topics in Frédéric Le Gal's work include Hepatitis B Virus Studies (38 papers), Hepatitis C virus research (38 papers) and Hepatitis Viruses Studies and Epidemiology (16 papers). Frédéric Le Gal is often cited by papers focused on Hepatitis B Virus Studies (38 papers), Hepatitis C virus research (38 papers) and Hepatitis Viruses Studies and Epidemiology (16 papers). Frédéric Le Gal collaborates with scholars based in France, Switzerland and Morocco. Frédéric Le Gal's co-authors include Emmanuel Gordien, Paul Dény, Ségolène Brichler, Elyanne Gault, Marie–Pierre Ripault, Chakib Alloui, Wael Mansour, Sylvie Chevret, Dominique Roulot and Jeanne Serpaggi and has published in prestigious journals such as Applied and Environmental Microbiology, Hepatology and Journal of Virology.

In The Last Decade

Frédéric Le Gal

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frédéric Le Gal France	22	1.4k	1.4k	173	60	53	45	1.6k
Karin Kidd‐Ljunggren Sweden	18	1.0k 0.7×	936 0.7×	169 1.0×	136 2.3×	18 0.3×	27	1.2k
Manon Deslauriers Canada	11	919 0.6×	787 0.6×	452 2.6×	116 1.9×	7 0.1×	14	1.2k
Soo‐Ok Kim South Korea	13	649 0.5×	530 0.4×	229 1.3×	146 2.4×	8 0.2×	29	925
Anna Ayres Australia	18	1.7k 1.2×	1.6k 1.2×	383 2.2×	78 1.3×	12 0.2×	18	1.8k
Fabrizia Pittaluga Italy	14	385 0.3×	220 0.2×	225 1.3×	50 0.8×	10 0.2×	33	572
Christophe M. Olinger Luxembourg	15	741 0.5×	430 0.3×	223 1.3×	61 1.0×	51 1.0×	18	916
Tomoko Kiyohara Japan	17	448 0.3×	569 0.4×	233 1.3×	124 2.1×	8 0.2×	35	837
Siew Lin Ngui United Kingdom	14	464 0.3×	539 0.4×	226 1.3×	17 0.3×	11 0.2×	26	658
Mulyanto Mulyanto Indonesia	19	353 0.2×	648 0.5×	347 2.0×	33 0.6×	10 0.2×	39	857
Jin-ye Yang China	13	502 0.4×	366 0.3×	218 1.3×	27 0.5×	7 0.1×	30	649

Countries citing papers authored by Frédéric Le Gal

Since Specialization

Citations

This map shows the geographic impact of Frédéric Le Gal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Le Gal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Le Gal more than expected).

Fields of papers citing papers by Frédéric Le Gal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Le Gal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Le Gal. The network helps show where Frédéric Le Gal may publish in the future.

Co-authorship network of co-authors of Frédéric Le Gal

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Le Gal. A scholar is included among the top collaborators of Frédéric Le Gal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Le Gal. Frédéric Le Gal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oliveira, José Luís, Ségolène Brichler, Juan Miguel Villalobos Salcêdo, et al.. (2025). A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D. Journal of Clinical Microbiology. 63(5). e0199924–e0199924. 3 indexed citations

Gal, Frédéric Le, Mohan Pandi, Aïda Sadikh Badiane, et al.. (2025). Hepatitis Delta and Liver Disease Among People Living With Hepatitis B With or Without HIV Co‐Infection in Senegal. Liver International. 45(3). e70026–e70026. 1 indexed citations

Gal, Frédéric Le, et al.. (2024). The Prevalence and Molecular Epidemiology of Hepatitis Delta Virus in Nigeria: The Results of a Nationwide Study. Viruses. 16(8). 1236–1236. 3 indexed citations

Tantet, Claire, Chakib Alloui, F. Méchaï, et al.. (2023). HIV-1 infection in South Kivu (Democratic Republic of Congo): high genotypic resistance to antiretrovirals. Journal of Antimicrobial Chemotherapy. 78(7). 1732–1739. 4 indexed citations

Rodriguez, Christophe, Ségolène Brichler, Chakib Alloui, et al.. (2021). Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV Genotype. Viruses. 13(8). 1572–1572. 12 indexed citations

Gal, Frédéric Le, Chakib Alloui, Dominique Roulot, et al.. (2021). Comprehensive Analysis of Hepatitis Delta Virus Assembly Determinants According to Genotypes: Lessons From a Study of 526 Hepatitis Delta Virus Clinical Strains. Frontiers in Microbiology. 12. 751531–751531. 4 indexed citations

Bazinet, Michel, Victor Pântea, Valentin Cebotarescu, et al.. (2017). Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial. The Lancet. Gastroenterology & hepatology. 2(12). 877–889. 187 indexed citations

Makiala‐Mandanda, Sheila, Frédéric Le Gal, Steve Ahuka‐Mundeke, et al.. (2017). High Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo. Journal of Clinical Microbiology. 55(5). 1299–1312. 28 indexed citations

Letang, Emílio, Aneth Vedastus Kalinjuma, Alex Ntamatungiro, et al.. (2016). Absence of hepatitis delta infection in a large rural HIV cohort in Tanzania. International Journal of Infectious Diseases. 46. 8–10. 14 indexed citations

10.

Mansour, Wael, Mathilde Lemoine, Frédéric Le Gal, et al.. (2014). Markers of hepatitis delta virus infection can be detected in follicular fluid and semen. Journal of Clinical Virology. 61(2). 279–281. 4 indexed citations

11.

Brichler, Ségolène, et al.. (2013). Commercial Real-Time Reverse Transcriptase PCR Assays Can Underestimate or Fail to Quantify Hepatitis Delta Virus Viremia. Clinical Gastroenterology and Hepatology. 11(6). 734–740. 35 indexed citations

12.

Servant‐Delmas, Annabelle, Frédéric Le Gal, Pierre Gallian, Emmanuel Gordien, & Syria Laperche. (2013). Increasing prevalence of HDV/HBV infection over 15 years in France. Journal of Clinical Virology. 59(2). 126–128. 43 indexed citations

13.

Gal, Frédéric Le, Selim Badur, Filiz Akyüz, et al.. (2012). Current hepatitis delta virus type 1 (HDV1) infections in central and eastern Turkey indicate a wide genetic diversity that is probably linked to different HDV1 origins. Archives of Virology. 157(4). 647–659. 28 indexed citations

14.

Brichler, Ségolène, et al.. (2010). A novel hepatitis B virus (HBV) subgenotype D (D8) strain, resulting from recombination between genotypes D and E, is circulating in Niger along with HBV/E strains. Journal of General Virology. 91(6). 1609–1620. 68 indexed citations

15.

Mansour, Wael, Alexandra Ducancelle, Frédéric Le Gal, et al.. (2009). Resolution of chronic hepatitis Delta after 1 year of combined therapy with pegylated interferon, tenofovir and emtricitabine. Journal of Clinical Virology. 47(1). 97–99. 19 indexed citations

16.

Malet, Isabelle, Frédéric Le Gal, Axelle Dehée, et al.. (2008). Variability of gB and gH genes of human herpesvirus‐6 among clinical specimens. Journal of Medical Virology. 80(7). 1211–1221. 25 indexed citations

17.

Gal, Frédéric Le, Elyanne Gault, Marie–Pierre Ripault, et al.. (2006). Eighth Major Clade for Hepatitis Delta Virus. Emerging infectious diseases. 12(7). 1447–1450. 151 indexed citations

18.

Castelnau, Corinne, Frédéric Le Gal, Marie–Pierre Ripault, et al.. (2006). Efficacy of peginterferon alpha-2b in chronic hepatitis delta: Relevance of quantitative RT-PCR for follow-up. Hepatology. 44(3). 728–735. 162 indexed citations

19.

Schneider, Véronique, Vincent Jeantils, Pascal Astagneau, et al.. (2000). Phylogenetic Analyses Indicate an Atypical Nurse-to-Patient Transmission of Human Immunodeficiency Virus Type 1. Journal of Virology. 74(6). 2525–2532. 47 indexed citations

20.

Dény, Paul, Giovanna Fattovich, Frédéric Le Gal, et al.. (1994). Polymerase-chain-reaction-based semi-quantification of hepatitis D viraemia in patients treated with high doses of α2b interferon. Research in Virology. 145(5). 287–295. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact